Thymosin alpha 1 therapy alleviates organ dysfunction of sepsis patients: a retrospective cohort study

Aim: Thymosin alpha 1 (Tα1) is a promising treatment for the improvement of sepsis patients. Until now, its function in reducing acute organ damage of sepsis patients is still unclear. The aim of this study was to determine whether Tα1 can alleviate organ dysfunction in sepsis patients. Methods: Th...

Disgrifiad llawn

Wedi'i Gadw mewn:
Manylion Llyfryddiaeth
Prif Awduron: Fei Pei, Yishan Liu, Lingyun Zuo, Bin Gu, Liqun Liang, Luhao Wang, Yao Nie, Minying Chen, Xiangdong Guan, Jianfeng Wu, on behalf of the China Critical Care Immunotherapy Research Group
Fformat: Artigo
Iaith:Inglês
Cyhoeddwyd: Open Exploration Publishing Inc. 2022-04-01
Cyfres:Exploration of Immunology
Pynciau:
immunoparalysis
immunotherapy
thymosin alpha 1
sepsis
sequential organ failure assessment score
Mynediad Ar-lein:https://www.explorationpub.com/Journals/ei/Article/100345
Tagiau: Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!

Eitemau Tebyg